PMID: 8598353Mar 1, 1996Paper

Endocavitary irradiation for early rectal carcinomas T1 (T2). A series of 101 patients treated with the Papillon's technique

International Journal of Radiation Oncology, Biology, Physics
J P GérardJ C Souquet

Abstract

This work is a retrospective analysis of a series of patients treated with endocavitary irradiation stressing the role of transrectal ultrasound (TRUS), which has been used routinely in the staging since 1987. Between 1977 and 1993, 101 patients with infiltrating adenocarcinomas were treated. Clinical staging was 65 T1 N0 and 36 T2 N0. TRUS used in 36 patients showed: 22 UT1 N0, 10 UT2 N0, and 3 UT2 N1. Contact x-ray was delivered with a 50 kV radiotherapy unit. The median dose was 92 Gy (60-125) in five fractions, 55 days. In 28 patients a boost was given with 192Ir implant delivering a median dose of 25 Gy/21 h. Complete response was observed in all patients at the completion of treatment. Loco-regional failures were seen in 14 patients (local in 7 patients, nodal pararectal in 6 patients, and local + nodal in 1 patient). A curative salvage treatment was attempted in 13 patients and resulted in an ultimate pelvic control rate of 99 patients. Rectal preservation was possible in 92 patients. Overall and specific 5-year survival was 83.3% and 94.4%. No serious complication was observed. TRUS was more sensitive than digital rectal examination to detect involvement of pararectal metastatic nodes (N1). No loco- regional relapse was...Continue Reading

References

Jan 1, 1992·American Journal of Surgery·G BuessH D Becker
Jul 1, 1991·The British Journal of Surgery·B NapoleonJ C Souquet
Sep 1, 1990·American Journal of Surgery·R A GrahamJ M Jessup
Aug 1, 1990·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·J C HoriotD Loiseau
Feb 1, 1990·Diseases of the Colon and Rectum·J DespretzM Julien
Apr 1, 1990·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·J Papillon
Dec 1, 1989·International Journal of Radiation Oncology, Biology, Physics·J PapillonJ M Ardiet
Jan 1, 1989·Archives of Surgery·D R McCreadyJ M Jessup
Jan 15, 1989·Cancer·J J DeCosseS S Sternberg
Sep 1, 1988·The British Journal of Surgery·B SischyD R Wilkinson
Feb 1, 1988·International Journal of Radiation Oncology, Biology, Physics·J J Kovalic
Nov 1, 1987·Diseases of the Colon and Rectum·I C LaveryD G Jagelman
Jan 1, 1985·Diseases of the Colon and Rectum·U Hildebrandt, G Feifel
Feb 1, 1986·Cancer·L Herrera-OrnelasD G Boyle
Sep 1, 1985·The British Journal of Surgery·R J NichollsP Boyle
Jul 1, 1994·The Australian and New Zealand Journal of Surgery·J P Gerard
Nov 15, 1993·International Journal of Radiation Oncology, Biology, Physics·G MarksL Masoni
Nov 1, 1993·The British Journal of Surgery·S P HuddyR J Heald
Mar 15, 1993·International Journal of Radiation Oncology, Biology, Physics·C S WongB J Cummings
Apr 1, 1993·Southern Medical Journal·C J BennettE M Copeland

❮ Previous
Next ❯

Citations

Jan 30, 2002·Journal of Surgical Oncology·William M MendenhallEdward M Copeland
May 27, 1999·Diseases of the Colon and Rectum·L Ruo, J G Guillem
Dec 16, 2010·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Asunción Hervás MorónEduardo Lobo Martínez
Mar 1, 1996·International Journal of Radiation Oncology, Biology, Physics·B D Minsky
Mar 19, 2004·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Olivier CoatmeurPhilippe Maingon
Jun 1, 2000·Annales de chirurgie·P Lasser, A Goharin
Sep 25, 2001·International Journal of Radiation Oncology, Biology, Physics·A AumockR J Myerson
Apr 16, 1998·International Journal of Radiation Oncology, Biology, Physics·P MaingonJ C Horiot
Aug 1, 1996·International Journal of Radiation Oncology, Biology, Physics·J P Gerard
Feb 17, 2000·Surgical Oncology·L Ruo, J G Guillem
Apr 8, 1998·The British Journal of Surgery·A G Heriot, D Kumar
Oct 7, 2003·American Journal of Clinical Oncology·Sophie LavertuJames A Martenson
Jul 14, 2009·American Journal of Clinical Oncology·William M MendenhallW Robert Rout
Mar 8, 2003·The Lancet Oncology·Jean-Pierre GerardOlivier Chapet
Nov 6, 2012·Journal of the American College of Radiology : JACR·Catherine DewhurstJudy Yee
Nov 18, 2008·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·M M LangeC J H van de Velde
Mar 14, 2009·The British Journal of Surgery·D ChristoforidisC O Finne
Jul 7, 2011·Expert Review of Medical Devices·Jean-Pierre GérardSerge Marcie
Jul 7, 2007·The Lancet Oncology·Brian D P O'NeillDiana M Tait
Sep 8, 2007·Clinical Oncology : a Journal of the Royal College of Radiologists·J P GerardP Romestaing
May 3, 2008·The Lancet Oncology·Harm J T RuttenCorrie A M Marijnen
Jun 7, 2008·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Vincenzo ValentiniChristine Verfaillie
Apr 10, 2010·Clinical Colorectal Cancer·Kristin A HigginsBrian G Czito

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.